TW202527936A - Ｇｌｐ—１受體調節劑之鹽形式 - Google Patents

Ｇｌｐ—１受體調節劑之鹽形式

Info

Publication number
TW202527936A
TW202527936A TW113148242A TW113148242A TW202527936A TW 202527936 A TW202527936 A TW 202527936A TW 113148242 A TW113148242 A TW 113148242A TW 113148242 A TW113148242 A TW 113148242A TW 202527936 A TW202527936 A TW 202527936A
Authority
TW
Taiwan
Prior art keywords
compound
salt
salt form
xrpd pattern
tert
Prior art date
Application number
TW113148242A
Other languages
English (en)
Chinese (zh)
Inventor
王曉陽
馬小玉
吳亞南
Original Assignee
美商卡默療法股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商卡默療法股份有限公司 filed Critical 美商卡默療法股份有限公司
Publication of TW202527936A publication Critical patent/TW202527936A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW113148242A 2023-12-11 2024-12-11 Ｇｌｐ—１受體調節劑之鹽形式 TW202527936A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2023137926 2023-12-11
WOPCT/CN2023/137926 2023-12-11

Publications (1)

Publication Number Publication Date
TW202527936A true TW202527936A (zh) 2025-07-16

Family

ID=94083674

Family Applications (1)

Application Number Title Priority Date Filing Date
TW113148242A TW202527936A (zh) 2023-12-11 2024-12-11 Ｇｌｐ—１受體調節劑之鹽形式

Country Status (3)

Country Link
AR (1) AR134641A1 (fr)
TW (1) TW202527936A (fr)
WO (1) WO2025128564A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2023008854A (es) 2021-01-28 2023-10-17 Carmot Therapeutics Inc Agonistas del receptor acoplado a proteinas g (gpcr), composiciones farmaceuticas que los comprenden y metodos para su uso.
WO2023182869A1 (fr) * 2022-03-25 2023-09-28 Ildong Pharmaceutical Co., Ltd. Nouveau sel de composé agoniste du récepteur glp-1, son procédé de préparation et composition pharmaceutique le comprenant
CN117362282B (zh) * 2022-07-07 2026-04-21 杭州德睿智药科技有限公司 Glp-1r激动剂的盐及其制备方法和应用

Also Published As

Publication number Publication date
WO2025128564A1 (fr) 2025-06-19
AR134641A1 (es) 2026-02-04

Similar Documents

Publication Publication Date Title
TWI831325B (zh) 作為atr抑制劑的萘啶衍生物及其製備方法
US12421234B1 (en) Solid state forms
KR102683492B1 (ko) 엘로빅시바트의 결정수식
CN101676266B (zh) 氘代的ω-二苯基脲及衍生物以及包含该化合物的药物组合物
EP2655369A1 (fr) Compositions et procédés de modulation des récepteurs farnésoïdes x
US20130012548A1 (en) Deuterium-substituted omega-diphenylurea and derivatives thereof and pharmaceutical compositions comprising the compounds
TWI837089B (zh) 製備雜環衍生化合物之方法、包括該化合物之組成物及該化合物之水合物
WO2016000568A1 (fr) Composé pour le traitement de la goutte
CA3246495A1 (fr) Nouveau sel de composé agoniste du récepteur glp-1, son procédé de préparation et composition pharmaceutique le comprenant
WO2025128564A1 (fr) Formes salines d'un modulateur du récepteur glp-1
WO2025128561A1 (fr) Formes cristallines d'un modulateur du récepteur glp-1
TWI894325B (zh) 含氮雜環化合物的鹽及其鹽的固體形式、藥物組合物和用途
WO2011077252A2 (fr) Co-cristaux de metaxalone
CN112823161B (zh) 共晶体及其用途
CN109232538B (zh) 一种1,2,4-三氮唑类化合物
WO2026008074A1 (fr) Forme cristalline d'un inhibiteur du facteur b du complément, son procédé de préparation et son utilisation
WO2026008053A1 (fr) Sel d'inhibiteur du facteur b du complément, son procédé de préparation et son utilisation
WO2026038156A1 (fr) Nouvelles formes cristallines
EA052301B1 (ru) Твердые формы
EA047565B1 (ru) Способ получения соединения гетероциклического производного, композиции, содержащей указанное соединение, и гидрата указанного соединения
WO2019070698A1 (fr) Nouvelles formes d'ibrutinib